OTCMKTS:TEAR TearLab (TEAR) Stock Price, News & Analysis → Buy these “two-bagger” stocks (From TradingTips) (Ad) Free TEAR Stock Alerts $0.06 0.00 (-1.86%) (As of 07/9/2020) Add Compare Share Share Today's Range$0.06▼$0.0650-Day Range$0.06▼$0.0652-Week Range$0.02▼$0.22Volume20,200 shsAverage Volume97,724 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get TearLab alerts: Email Address Ad Insiders ExposedHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover About TearLab Stock (OTCMKTS:TEAR)TearLab Corporation operates as an in-vitro diagnostic company in the United States and internationally. It offers TearLab Osmolority System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease; and enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. Its TearLab Osmolarity System consists of TearLab disposable, a single-use microfluidic microchip; TearLab pen, a hand-held device that interfaces with the TearLab disposable; and TearLab reader, a small desktop unit that allows for the docking of the TearLab pen, as well as provides a quantitative reading for the operator. The company was formerly known as OccuLogix, Inc. TearLab Corporation was founded in 1996 and is headquartered in San Diego, California.Read More TEAR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TEAR Stock News HeadlinesJanuary 29, 2024 | finance.yahoo.comHarrow Announces New Appointments to its Board of DirectorsOctober 30, 2023 | benzinga.comSTRATA Skin Science Announces Leadership ChangeJuly 12, 2023 | finance.yahoo.comOcular Therapeutix™ Announces Appointment of New Board MemberJanuary 15, 2023 | marketwatch.comOcular Allergy Diagnostic Systems Market Size 2023 with End-user Industries, Segments Covered in the ReportSeptember 9, 2022 | yahoo.comHousing Authority officials want more police help at East AcresSeptember 9, 2022 | yahoo.comLawrence schools on 'good footing' financiallySeptember 9, 2022 | nz.finance.yahoo.comPathway Makes Four Senior PromotionsSeptember 7, 2022 | apnews.comTearLab® Announces Corporate Name Change to Trukera™ Medical, Positions Company for Further Expansion in Corneal HealthJuly 20, 2022 | thestreet.comCramer's Top Stock Picks: CLDX OXY TEAR TSLAJune 8, 2022 | finance.yahoo.comNacuity Pharmaceuticals Strengthens Scientific Advisory Board with Appointment of Nancy Holekamp, M.D., and Richard L. Lindstrom, M.D. - Yahoo FinanceMay 23, 2022 | marketscreener.comAXIM BIOTECHNOLOGIES, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q) - Marketscreener.comMay 20, 2022 | marketscreener.comGreenbrook TMS : NOTICE OF ANNUAL MEETING OF SHAREHOLDERS - Form 6-K - Marketscreener.comMay 12, 2022 | streetinsider.comXequel Bio, Inc. Appoints Veteran Pharmaceutical Executives to Advance Next Stage of Corporate Growth - StreetInsider.comMay 11, 2022 | benzinga.comXequel Bio, Inc. Appoints Veteran Pharmaceutical Executives to Advance Next Stage of Corporate Growth - B - BenzingaMay 11, 2022 | globenewswire.comXequel Bio, Inc. Appoints Veteran Pharmaceutical Executives to Advance Next Stage of Corporate Growth - GlobeNewswireApril 12, 2022 | streetinsider.comForm DEF 14A LENSAR, Inc. For: May 25 - StreetInsider.comDecember 10, 2021 | finance.yahoo.comTearLab Corporation Announces Adam Szaronos as President and Chief Executive Officer, and Jim Mazzo as Executive Chairman of the BoardNovember 10, 2021 | markets.businessinsider.comTearLab Positioned For Growth With Jim Mazzo Joining Board of DirectorsNovember 9, 2021 | prnewswire.comTearLab Positioned For Growth With Jim Mazzo Joining Board of Directors - PRNewswireNovember 3, 2021 | seekingalpha.comAmgen, Inc. (AMGN) CEO Bob Bradway on Q3 2021 Results - Earnings Call Transcript - Seeking AlphaOctober 6, 2021 | streetinsider.comAXIM® Biotechnologies Appoints Senior DED Expert Dr. Laura Periman to its Medical Advisory Board - StreetInsider.comOctober 5, 2021 | finance.yahoo.comAXIM® Biotechnologies Appoints Senior DED Expert Dr. Laura Periman to its Medical Advisory Board - Yahoo FinanceOctober 4, 2021 | streetinsider.comOrasis Pharmaceuticals Appoints Julie Speed as Senior Vice President, Head of Strategy and Marketing to Lead Commercial Growth Plan - StreetInsider.comSeptember 17, 2021 | prnewswire.comMellingMedical and TearLab Agreement Aims to Enhance Early Detection of Dry Eye Disease in American Veterans - PRNewswireSee More Headlines Receive TEAR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for TearLab and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/08/2019Today6/17/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolOTCMKTS:TEAR Previous SymbolNASDAQ:TEAR CUSIPN/A CIK1299139 Webwww.tearlab.com Phone858-455-6006Fax858-812-0540Employees34Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesMr. Elias Vamvakas (Age 60)Exec. Chairman & Sec. Mr. Joseph S. Jensen (Age 47)CEO & Director Mr. Michael Marquez (Age 37)Chief Financial Officer Dr. Benjamin Sullivan Ph.D. (Age 43)Chief Scientific Officer Mr. Sam FakhouryVP of Quality, Compliance & Supply ChainKey CompetitorsAdynxxOTCMKTS:ADYXCalmare TherapeuticsOTCMKTS:CTTCDex LiquidatingOTCMKTS:DXTRQEndologixOTCMKTS:ELGXQHypertension DiagnosticsOTCMKTS:HDIIView All Competitors TEAR Stock Analysis - Frequently Asked Questions How have TEAR shares performed in 2024? TearLab's stock was trading at $0.0579 at the beginning of 2024. Since then, TEAR stock has increased by 0.0% and is now trading at $0.0579. View the best growth stocks for 2024 here. How were TearLab's earnings last quarter? TearLab Co. (OTCMKTS:TEAR) released its quarterly earnings results on Thursday, August, 8th. The medical research company reported ($0.10) EPS for the quarter. The medical research company earned $5.85 million during the quarter. When did TearLab's stock split? Shares of TearLab reverse split on the morning of Friday, February 24th 2017. The 1-10 reverse split was announced on Friday, February 24th 2017. The number of shares owned by shareholders was adjusted after the market closes on Thursday, February 23rd 2017. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. What other stocks do shareholders of TearLab own? Based on aggregate information from My MarketBeat watchlists, some companies that other TearLab investors own include Vertex Energy (VTNR), SCYNEXIS (SCYX), Synergy Pharmaceuticals (SGYP), Immunomedics (IMMU), Verastem (VSTM), Biocept (BIOC) and MEI Pharma (MEIP). How do I buy shares of TearLab? Shares of TEAR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:TEAR) was last updated on 6/17/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored(Free Workshop) Advanced “bug-out bag” hacks!“Do you have a ‘bug-out bag’ (survival kit) ready to grab-and-go when a disaster or other crisis strikes?” ...Warrior Life | SponsoredThe Scary Fed Idea To Turn Your Dollars Into a Digital Power GrabCash is becoming a relic of the past… Soon, Biden and the Federal Reserve plan to replace the dollar with t...Oasis Gold | Sponsored"Trump Loophole" Beats InflationThe demise of the "petrodollar" appears imminent. And the implications for Americans could be dire.Colonial Metals | SponsoredNvidia’s Quiet $1 Trillion PivotNvidia recently added $277 billion in market cap … IN ONE DAY.Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TearLab Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share TearLab With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.